Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Asset Utilization Ratio (2024 - 2025)

Historic Asset Utilization Ratio for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q3 2025 value amounting to 0.08.

  • Zentalis Pharmaceuticals' Asset Utilization Ratio fell 807.05% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08, marking a year-over-year decrease of 807.05%. This contributed to the annual value of 0.14 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported Asset Utilization Ratio of 0.08 as of Q3 2025, which was down 807.05% from 0.07 recorded in Q2 2025.
  • Over the past 5 years, Zentalis Pharmaceuticals' Asset Utilization Ratio peaked at 0.15 during Q4 2024, and registered a low of 0.07 during Q1 2025.